With medicines and prescribing teams now working together across the end-to-end patient pathway – this is a new era for medicines optimisation.
Medicines have the potential to make a significant contribution to how ICSs address health inequalities, manage population health, improve patient care – all within financial constraints.
But this is an untrodden path, with much still to share and learn.
HSJ started this critical conversation at the ICS Medicines Forum in October. In this webinar we will drill down further into the opportunities for medicines optimisation in this new operating environment.
Crucially, our expert panellists will try to prioritise where and how medicines optimisation can help to solve some of today’s immediate and urgent challenges.
This HSJ webinar, in association with Spirit Health, will ask:
*What opportunities does this new operating environment present for medicines optimisation?
*How can shared datasets and new funding structures be harnessed to drive the redesign of care pathways, to improve services and reduce costs?
*Where do the opportunities for better use of pharmacy resources and medicines optimisation lie? How can these be made a priority given the enormous agenda for ICSs?
*How can medicines optimisation be made “ICS wide” – with a consistent approach across primary and secondary care and community pharmacy?